Characteristic | New T2D | Known T2D | P-value |
---|---|---|---|
Sex (n; male/female) | 569/462 | 656/662 | 0.009 |
Age (years) | 55.0 ± 12.0 | 58.7 ± 10.8 | < 0.001 |
BMI (kg/m2) | 29.9 ± 5.2 | 30.5 ± 5.5 | 0.009 |
Waist (cm) | 103 ± 13 | 104 ± 14 | 0.009 |
Systolic BP (mmHg) | 136 ± 17 | 135 ± 17 | 0.103 |
Diastolic BP (mmHg) | 78 ± 10 | 75 ± 9 | < 0.001 |
Heart rate (bpm) | 73 ± 12 | 74 ± 12 | 0.827 |
Creatinine (μmol/l) | 75 ± 16 | 74 ± 17 | 0.052 |
eGFR (ml/min/1.73m2) | 90 ± 16 | 88 ± 17 | 0.003 |
Total cholesterol (mmol/l) | 5.3 ± 1.2 | 4.5 ± 1.0 | < 0.001 |
HDL-cholesterol (mmol/l) | 1.26 ± 0.36 | 1.27 ± 0.36 | 0.433 |
LDL-cholesterol (mmol/l) | 3.4 ± 1.0 | 2.7 ± 0.9 | < 0.001 |
Triacylglycerol (mmol/l) | 1.88 ± 1.30 | 1.70 ± 1.11 | < 0.001 |
Glucose (mmol/l) | 7.6 ± 2.3 | 7.6 ± 2.1 | 0.747 |
HbA1c (mmol/mol) | 49 ± 14 | 52 ± 11 | < 0.001 |
HbA1c (%) | 6.7 ± 1.2 | 6.9 ± 1.0 | < 0.001 |
Current smoking (%) | 23.7 | 14.4 | < 0.001 |
Former smoking (%) | 42.5 | 51.1 | < 0.001 |
% w. BP-lowering therapy | 35.7 | 63.4 | < 0.001 |
% w. statins | 20.1 | 63.0 | < 0.001 |
Skin autofluorescence (AU) | 2.25 ± 0.50 | 2.42 ± 0.54 | < 0.001 |
SAF z score | 0.34 ± 0.89 | 0.56 ± 0.99 | < 0.001 |